Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1975 May 10;2(5966):309–310. doi: 10.1136/bmj.2.5966.309

Clinical trial of mebendazole, a broad-spectrum anthelminthic.

J G Hutchison, N M Johnston, M V Plevey, I Thangkhiew, C Aidney
PMCID: PMC1681918  PMID: 1131521

Abstract

Eighty-five children aged 5-14 years who were infested with worms were treated with mebendazole 100 mg twice daily for three days. The percentage cure rates were ascaris 100%, trichuris 94%, hookworm 82%, and hymenolepis 39%. The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen A. V., Ridley D. S. Further observations on the formol-ether concentration technique for faecal parasites. J Clin Pathol. 1970 Sep;23(6):545–546. doi: 10.1136/jcp.23.6.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brugmans J. P., Thienpont D. C., van Wijngaarden I., Vanparijs O. F., Schuermans V. L., Lauwers H. L. Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects. JAMA. 1971 Jul 19;217(3):313–316. [PubMed] [Google Scholar]
  3. Thompson R. G., Hutchison J. G., Johnston N. M. Survey of intestinal pathogens from immigrant children. Br Med J. 1972 Mar 4;1(5800):591–594. doi: 10.1136/bmj.1.5800.591. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES